Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad060 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Elizabeth Hastie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Long-term consequences of human immunodeficiency virus (HIV) are likely the result of persistent inflammation and immune dysfunction of which cytomegalovirus (CMV) is a known contributor. We leveraged 2 AIDS Clinical Trials Group clinical trials exploring the effects of immune modulators (ruxolitinib and sirolimus) on inflammation in people with HIV on antiretroviral therapy to determine whether these interventions affected CMV shedding at various mucosal sites. Analyzing 635 mucosal samples collected, we found no significant difference in CMV levels across study arms or time points. Men had more CMV shedding than women. We did confirm an association between higher CMV DNA and immune markers associated with HIV persistence and HIV-associated mortality rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California San Diego, San Diego, California, USA.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Medicine, Emory Vaccine Center, Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia, USA.
- Department of Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID-Profile: Elizabeth Hastie, Peter Hunt
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Hastie, E., Moser, C., Sun, X., Lennox, J., Hsue, P. Y., Bosch, R. J., Deeks, S., Meneses, M. V., Lederman, M. M., Hunt, P., Henrich, T. J., Marconi, V. C., & Gianella, S. (2023). Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad060
Vancouver
Hastie E, Moser C, Sun X, Lennox J, Hsue PY, Bosch RJ, et al. Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad060
BibTeX
@article{Hastie2023,
author = {Hastie, Elizabeth and Moser, Carlee and Sun, Xin and Lennox, Jeffrey and Hsue, Priscilla Y and Bosch, Ronald J and Deeks, Steven and Meneses, Milenka V and Lederman, Michael M and Hunt, Peter and Henrich, Timothy J and Marconi, Vincent C and Gianella, Sara},
title = {Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad060}
}
EUVIMED